Sign in
8-K

Current Report

Matinas BioPharma Holdings, Inc. Filed Acc 0001641172-25-008417

Shareholder rights changed · Executive or director change · Director nominations · Other events

  • Item 3.03 Material modification to rights of security holders
  • Item 5.02 Departure or appointment of directors or officers
  • Item 5.08 Shareholder director nominations
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading form8-k.htm…